Clinical Trials Logo

Oxidative Stress clinical trials

View clinical trials related to Oxidative Stress.

Filter by:

NCT ID: NCT05982665 Completed - Inflammation Clinical Trials

Effect of Inhaled Molecular Hydrogen on Recovery Process After Downhill Walking on the Treadmill

Start date: August 14, 2023
Phase: N/A
Study type: Interventional

This study assesses the effect of molecular hydrogen inhalation in healthy males on muscle soreness, fatigue, oxidative stress, and inflammation following eccentric muscle contraction during downhill walking on the treadmill.

NCT ID: NCT05958927 Recruiting - Oxidative Stress Clinical Trials

Fundus Findings and Thiol-Disulfide Homeostais

Start date: April 13, 2023
Phase:
Study type: Observational

Gestational diabetes mellitus is associated with abnormal blood sugar levels throughout pregnancy in women without prior diabetes. Many studies have been conducted on the relationship between diabetes and oxidative stress. In this study, it was aimed to investigate the presence of fundus findings in patients with gestational diabetes and/or impaired blood sugar based on the results of previous studies and to simultaneously investigate the thiol-disulfide homeostasis in the tears of the patients.There was no previous study in the literature on thiol disulfide homeostasis in tears in gestational diabetic patients.

NCT ID: NCT05946798 Recruiting - Oxidative Stress Clinical Trials

Role of NADPH Oxidase in Microvascular Dysfunction Following GDM

Start date: August 30, 2023
Phase: Early Phase 1
Study type: Interventional

The purpose of this investigation is to examine NADPH oxidase as a source of reactive oxygen species contributing to aberrant microvascular function in otherwise healthy women with a history of GDM.

NCT ID: NCT05931315 Completed - Quality of Life Clinical Trials

A Study to Assess the Efficacy of CaroRiteā„¢ on Psychological Well-being, Oxidative Stress and Quality of Life in Healthy Individuals

Start date: August 22, 2023
Phase: N/A
Study type: Interventional

The present study is a randomized, placebo-controlled, double-blind clinical study in which 94 individuals will be screened, and considering a screening failure rate of 20%, approximately 76 participants will be randomized in a ratio of 1:1 to receive either CaroRiteā„¢ or placebo and will be assigned a unique randomization code. Each group will have at least 30 completed participants after accounting for a dropout/withdrawal rate of 20%. The intervention duration for all the study participants is 90 days.

NCT ID: NCT05908513 Withdrawn - Diabetes Mellitus Clinical Trials

NAC Treatment and Outcomes in Patients With Advanced Atherosclerosis and DM

RENEWAL
Start date: October 15, 2021
Phase: Phase 1
Study type: Interventional

Atherosclerosis and diabetes are related to coronary artery disease and peripheral artery disease. The mechanisms are related to increased reactive oxygen species (ROS) formation and inflammatory cytokine secretion. However, simply using antioxidant or anti-inflammatory therapies has no optimal outcomes. On the other hand, N-acetylcysteine (NAC) which has both antioxidant and anti-inflammatory effects could effectively attenuate ROS production and reduce vascular inflammation. Hence, we will investigate the effect of NAC treatment on the outcomes in patients with advanced atherosclerotic heart diseases and patients with diabetes combined with significant peripheral artery disease.

NCT ID: NCT05897450 Not yet recruiting - Pain, Postoperative Clinical Trials

The Effects of TAP Block on Thiol/Disulfide Homeostasis and Pain in Laparoscopic Gynecological Surgery

Start date: July 1, 2023
Phase:
Study type: Observational

In the study, it was aimed to compare patients who underwent laparoscopic gynecological surgery with and without TAP block in terms of postoperative pain levels and Thiol/Disulfide homeostasis. In addition, the relationship between postoperative pain levels and Thiol/Disulfide homeostasis will be investigated.

NCT ID: NCT05895331 Not yet recruiting - Oxidative Stress Clinical Trials

The Effects of Dexmedetomidine on Thiol/Disulphide Homeostasis in Coronary Bypass Surgery

Start date: June 5, 2023
Phase:
Study type: Observational

Dexmedetomidine (DEX) is a sedative and anesthetic drug with known antioxidant properties.In this study, it was aimed to investigate the oxidative stress levels in patients undergoing on-pump CABG by measuring the thiol/disulfide levels and to investigate the effects of dexmedetomidine infusion used in Coronary Bypass Surgery on dynamic Thiol/Disulphide Homeostasis.

NCT ID: NCT05873530 Completed - Oxidative Stress Clinical Trials

Circadian Modulation of Grape Consumption and Oxidative Stress Response

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

This study investigated the effects of time-of-day of grape consumption on high-fat meal-induced oxidative stress.

NCT ID: NCT05862987 Completed - Oxidative Stress Clinical Trials

The Effect of Hydrogen Rich Water Intake on Acute Body Response and Following Recovery After 5 km Run in Untrained Men

Start date: May 22, 2023
Phase: N/A
Study type: Interventional

The aim of this randomized, double blinded, placebo controlled cross-over study is to evaluate the effect of hydrogen rich water intake on running performance, physiological and biochemical variables during endurance exercise and following recovery in endurance-untrained men.

NCT ID: NCT05861206 Completed - Inflammation Clinical Trials

Efficacy of Green and White Tea Extract Mouthwashes in the Management of Plaque-induced Gingivitis: A Clinical and Biochemical Study

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

Background and objective: Tea is the second most consumed drink in the world after water. Gingivitis is among the most common infectious diseases. In this clinical study, Chlorhexidine Gluconate (CHX) was chosen as the positive control group and the clinical and biochemical efficacy of mouthwashes with green tea, white tea and essential oil (EO) as the active ingredients were aimed to be examined comprehensively. Methods: 112 participants with gingivitis were randomly assigned to 4 different groups that different mouthwashes were used for 4 weeks. CHX-MW group (0.12% CHX, as a positive control group), EO-MW group (Listerine), GT-MW group (5% Green tea), and WT-MW group (5% White tea). The effects of the mouthwashes on plaque, inflammation, and dental staining were evaluated by indexed scores at the beginning and the end of the 4th week. In addition, markers related to gingival inflammation (IL-1beta, MMP-8) and oxidative stress (TOS, TAS, OSI (TOS/TAS)) were evaluated on samples from the gingival crevicular fluid.